CAAP Company: Medella Health Community Diabetes Survey

Medella Health's wearable technology features the next generation of bio-sensors and electronics that will help people better manage their health. 

Participate in the survey to help further knowledge of glucose monitoring and enhance diabetes care.

Yes! I'll take the survey

Previous
Previous

Ontario Bioscience Innovation Organization Announces a Call for Applications for the 2017 Capital Access Advisory Program

Next
Next

Pre-CAAP Company: Ourotech Presents at Wall Street Journal Conference & Featured on the WSJ Website